Shire changes NASDAQ ticker symbol to SHPG starting Wednesday
With the opening of trading on Wednesday, Shire plc's American Starting Wednesday, Shire's American Depository Shares will change ticker symbols on the NASDAQ market from SHPGY to SHPG.
Shire changes NASDAQ ticker symbol to SHPG starting Wednesday
David Sell
With the opening of trading on Wednesday, Shire plc's American Depository Shares will change ticker symbols on the NASDAQ market, from SHPGY to SHPG.
The loss of the "Y" on the NASDAQ will have no effect on trading on the London Stock Exchange, where Shire's regular share are bought and sold using the symbol SHP.
Meanwhile, Shire shares had a bit of turmoil in recent days as traders reacted to the FDA approval of a competitor's generic application for Shire's attention deficit hyperactivity disorder (ADHD) drug Adderall XR.
Shire, which has a facility in Wayne, Pa., says each ADS continues to represent three ordinary shares of Shire plc.
On June 25, the Actavis Group, a generic pharmaceuticals company, in Morristown, N.J., said it got approval to market its generic version. Watson Pharmaceuticals said in April that it will buy Actavis for about $5.6 billion. Watson's headquarters is in Parsippany, N.J.
Previously, Teva Pharmaceuticals and Impax Laboratories had marketed generic versions of Adderall XR but they were working in conjunction with Shire. Such arrangements don't lower the price of a drug as much as independent generic drugs do.
The Wall Street Journal reported that some stock analysts were not particularly bothered since Shire's reliance on Adderall XR has waned a bit because of increased sales of a newer ADHD drug, Vyvanse. A link to the Journal story is here.
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog
